The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by ghrelin including anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus.

 
Web www.patentalert.com

< Nf-kb activation inhibitors

< Implantable medical lead with reinforced outer jacket

> Implantable medical lead

> Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

~ 00257